India

IHH Healthcare India appoints Shriram Vijayakumar as CEO

He joined the company as the COO of its India Operations Division in 2019.

India's Max Healthcare bags $165m in fundraising round

Proceeds will be used partly for meeting the company’s capital spending.

Launch of generic oncology drugs underway in India

The government has approved generic versions of a kidney cancer drug.

Fortis Memorial Research Institute launches pediatric tumor clinic

The clinic aims to treat children with a variety of solid tumors and cancers.

Private sector growth boosts India's medical devices market

The country could rely more on the sector due to rising healthcare expectations.

Indian telehealth startup MFine bags $16m in funding round

The funds will be partly used towards tripling its investment in AI.

India needs to invest in resilient healthcare information infrastructure: report

Risk communication emerged as the weakest link during the pandemic.

Are India's underfunded hospitals equipped to deal with the pandemic?

The country is unable to raise healthcare expenditure by more than 3.8% of GDP, compared to the APAC average of 6.64%.

India medicine sales to increase 9.4% by 2029

Telemedicine service is expected to prevail in the coming years.

India's worst-hit state creates stir over sourcing of COVID-19 drug

The government and private sector were urged to collaborate on its pricing.

New potential COVID-19 drug a boon for India's pharmas

It could help address issues such as shortage of ventilators.

India slated to lead in pharma exports: analyst

Forecast shows India’s pharmaceutical export value will rise to US$30.8b by 2024.

India urged to ramp up healthcare spending

The country ranked at 170 out of 188 countries in health expenditure.

India's hospitals reel from outpatient slump

People have been reluctant to visit hospitals out of fear of the pandemic.

Lack of funding, infrastructure looms over India's healthcare sector

The country only has 8 physicians per 10,000 population.

India bans exports of alleged coronavirus drug

It will be limited to fulfilling existing contracts and humanitarian grounds.